predominant CA-MRSA strain in the United States (USA300) to spread in Europe was also recently documented, using whole-genome analysis, by Glaser et al [2] and Toleman et al [3] in France and the United Kingdom, respectively. Both studies demonstrated that USA300 genomes isolated in Europe are phylogenetically interspersed with US isolates, suggesting multiple introductions and multiple failures to establish endemic transmission.
Of particular interest in the article by von Dach et al was an apparent link of some CA-MRSA isolates to recent travel or prior residence in South America. Specifically, several isolates were associated with the northern region of South America, specifically Colombia and Ecuador. The genomes of these isolates formed a robust clade, were susceptible to fluoroquinolones and erythromycin, possessed a variant of the methicillin resistance cassette (IVc), and lacked the arginine catabolic mobile element (ACME) that is commonly found in USA300 strains from North America. These characteristics are all features of the so-called Latin American variant (LV) of USA300 that was first isolated in 2005 [4, 5] . We recently reported that a specific clade of USA300-LV constitutes a parallel USA300 epidemic affecting predominantly northern South American countries [6] . This South American epidemic clade, the USA300-SAE lineage, is characterized by a unique genomic region encoding copper and mercury resistance factors (COMERs).
Because of the strong similarities of USA300-SAE to the Swiss isolates associated with South America, we were surprised that von Dach et al did not find evidence of the COMER region in their whole-genome sequences. Using a basic BLAST strategy on the publically available genomes from the study by von Dach et al, we were able to identify the COMER region in 10 of 12 genomes from the ACME-negative isolates (Figure 1) . The only 2 genomes that did not have COMERs (labeled S15 and S19) were isolates from a single family. The COMER locus was also present in all the other publically available genomes that grouped in the ACME-negative clade in the article by von Dach et al. These genomes, in fact, were isolated in northern Manhattan and the Bronx, which both have large communities of individuals of Latin American origin [7] . These findings show that the USA300-SAE clade has now been isolated in both North and South America, as well as in Europe, and the detection of the COMER locus could serve as a tool to monitor its spread. This finding may also support the idea that the copB locus (the only region found both in ACME and COMER) may be an important contributor to the enhanced fitness and success of this lineage. These findings also highlight the importance of detailed wholegenome characterization of epidemic strains that could help explain evolutionary and phylogeographic determinants of virulence and transmission.
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